Clinton Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.35M Buy
+12,256
New +$1.28M 0.48% 57
2018
Q2
Sell
-38,558
Closed -$3.2M 514
2018
Q1
$3.2M Buy
+38,558
New +$3.43M 0.34% 96
2017
Q4
Sell
-86,773
Closed -$6.61M 539
2017
Q3
$6.61M Buy
86,773
+70,704
+440% +$5.34M 0.73% 32
2017
Q2
$1.21M Buy
+16,069
New +$1.11M 0.12% 258
2017
Q1
Sell
-14,286
Closed -$787K 1088
2016
Q4
$787K Buy
+14,286
New +$784K 0.05% 438
2016
Q3
Sell
-98,963
Closed -$4.13M 1112
2016
Q2
$4.13M Buy
+98,963
New +$4.56M 0.18% 152

Other funds holding PRAH

Clinton Group's PRAH Position: Q3 2018 in Review

Clinton Group opened a new position in PRA Health Sciences, Inc. (PRAH) in Q3 2018: 12,256 shares worth $1.35M. The stake represents 0.48% of the portfolio and ranks #57 among its holdings. This is a return to the name: Clinton Group previously reported a position in PRAH as recently as Q1 2018.

Clinton Group first reported a position in PRAH in Q2 2016 and has held it in 6 quarters since. The position peaked at $6.61M in Q3 2017. 342 funds tracked by Wall St. Rank hold PRAH as of Q3 2018.

  • Clinton Group held 12,256 shares of PRA Health Sciences, Inc. worth $1.35M as of Q3 2018.
  • PRA Health Sciences, Inc. was a new Clinton Group position in Q3 2018.
  • PRA Health Sciences, Inc. made up 0.48% of Clinton Group's portfolio in Q3 2018, its #57 holding.
  • Clinton Group first reported a position in PRA Health Sciences, Inc. in Q2 2016 and has held it in 6 quarters since.
  • Clinton Group's PRA Health Sciences, Inc. position peaked at $6.61M in Q3 2017.
  • 342 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.